Guardant Health
GH
#1122
Rank
ยฃ15.78 B
Marketcap
ยฃ116.67
Share price
-2.17%
Change (1 day)
56.95%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -ยฃ4.12

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.62. In 2022 the company made an earnings per share (EPS) of -ยฃ4.81 a decrease over its 2021 EPS that were of -ยฃ3.00.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ4.12-14.2%
2022-ยฃ4.8160%
2021-ยฃ3.0055.04%
2020-ยฃ1.94207.14%
2019-ยฃ0.63-19.81%
2018-ยฃ0.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ0.19-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.84-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA